Advertisement
Advertisement
TMO
Thermo Fisher Scientific, Inc.
464.13
USDSponsored
-11.75
-2.47%
Mar 13, 16:00 UTC -4
Closed
After-Market
461.95
-2.19
-0.47%
TMO Earnings Reports
Positive Surprise Ratio
TMO beat 34 of 40 last estimates.
85%
Next Report
Date of Next Report
Apr 21, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.96B
/$5.29
Implied change from Q4 25 (Revenue/ EPS)
-10.31%
/-19.48%
Implied change from Q1 25 (Revenue/ EPS)
+5.70%
/+2.72%
Thermo Fisher Scientific, Inc. earnings per share and revenue
On Jan 29, 2026, TMO reported earnings of 6.57 USD per share (EPS) for Q4 25, beating the estimate of 6.51 USD, resulting in a 0.91% surprise. Revenue reached 12.21 billion, compared to an expected 12.07 billion, with a 1.21% difference. The market reacted with a -2.61% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 18 analysts forecast an EPS of 5.29 USD, with revenue projected to reach 10.96 billion USD, implying an decrease of -19.48% EPS, and decrease of -10.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alpha Tau Medical Ltd. Ordinary Shares
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.08
Surprise
+36.51%
Neuropace, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.15
Actual
-$0.08
Surprise
+48.22%
Sight Sciences, Inc. Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.08
Surprise
+43.66%
908 Devices Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.07
Actual
$0.10
Surprise
+240.06%
Stereotaxis, Inc. Common Stock
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.06
Surprise
+10.04%
Rapid Micro Biosystems, Inc. Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.22
Actual
-$0.28
Surprise
-23.35%
Nuwellis, Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$1.59
Actual
-$1.50
Surprise
+5.73%
FAQ
What were Thermo Fisher Scientific, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Thermo Fisher Scientific, Inc. reported EPS of $6.57, beating estimates by 0.91%, and revenue of $12.21B, 1.21% above expectations.
How did the market react to Thermo Fisher Scientific, Inc.'s Q4 2025 earnings?
The stock price moved down -2.61%, changed from $608.02 before the earnings release to $592.16 the day after.
When is Thermo Fisher Scientific, Inc. expected to report next?
The next earning report is scheduled for Apr 21, 2026.
What are the forecasts for Thermo Fisher Scientific, Inc.'s next earnings report?
Based on 18
analysts, Thermo Fisher Scientific, Inc. is expected to report EPS of $5.29 and revenue of $10.96B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement